TheEdgeResearch
Home / Stocks / NBGV

NewBridge Global Ventures, Inc. (NBGV)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$769,176
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-18.32
52-Wk Range
1.0E-4-1.0E-4
CEO
Chris Bourdon
Country
US
Currency
USD

NewBridge Global Ventures, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Alameda, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $769,176. Its beta of -18.32 implies it has historically moved less than the broad market.

Company profile
Exchange
Other OTC
Employees
6
IPO date
1996-09-18
Headquarters
Alameda, CA, US
About NewBridge Global Ventures, Inc.

NewBridge Global Ventures, Inc. (NBGV), operating through its various subsidiaries, is actively engaged in California's cannabis industry. The company focuses on cultivating, manufacturing, and distributing products for both medical and recreational use across the state. Furthermore, NewBridge Global Ventures extends its expertise by offering advisory services to other cannabis businesses, including cultivators, processors, and retail brands. The firm also manages real estate holdings, and its corporate headquarters are located in Alameda, California.

Comparable companies

NewBridge Global Ventures, Inc. is most often compared with the following Healthcare names:

CLAZFCNBIGNOWLAXAFLTTSFPCNTPRXTFSBUDFSLGWFSPLIF
More research on NBGV
NBGV technical analysis NBGV TheEdge Score Compare against peers
Open full interactive analysis & DCF →